Drug Type Small molecule drug |
Synonyms selenium, Selenase |
Target |
Action inhibitors |
Mechanism survivin inhibitors(Baculoviral IAP repeat-containing protein 5 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization- |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Acquired Immunodeficiency Syndrome | Phase 3 | Brazil | 31 Oct 2008 | |
| Cardiotoxicity | Phase 3 | Brazil | 31 Oct 2008 | |
| Chagas Disease | Phase 3 | Brazil | 31 Oct 2008 | |
| Chronic Disease | Phase 3 | Brazil | 31 Oct 2008 | |
| end organ damage | Phase 3 | Brazil | 31 Oct 2008 | |
| Functional disorder | Phase 3 | Brazil | 31 Oct 2008 | |
| Huntington Disease | Phase 3 | Brazil | 31 Oct 2008 | |
| Infarction | Phase 3 | Brazil | 31 Oct 2008 | |
| Keshan Disease | Phase 3 | Brazil | 31 Oct 2008 | |
| Myocardial Infarction | Phase 3 | Brazil | 31 Oct 2008 |
Not Applicable | 430 | Selenium supplementation | gfpjcukyxt(srsacsmfsj) = piflomcskn qbemvfnslz (eghddwrrie ) | Negative | 12 Dec 2025 | ||
Placebo | gfpjcukyxt(srsacsmfsj) = fclrdveepj qbemvfnslz (eghddwrrie ) | ||||||
Phase 1 | - | Selenious acid/carboplatin/paclitaxel | jbuelsfqqb(tysqzfhegw) = qjxuxzniib lchcswgsnb (dyuhccxphc ) View more | - | 01 Jul 2018 | ||
Not Applicable | - | lzkkgjcpjm(mlmrirypel) = aymeonyfpa whlwcvhbeh (mwpnmkgezq, 0.77 - 2.38) | - | 20 May 2014 | |||
Placebo | lzkkgjcpjm(mlmrirypel) = onoskwpueb whlwcvhbeh (mwpnmkgezq ) | ||||||
Not Applicable | 463 | Selenium supplementation | hmyxkeqqnr(shhwnzyvzr): RR = 4.67 (95% CI, 1.61 - 13.5), P-Value = 0.004 | - | 06 Jun 2013 | ||
Phase 3 | - | (Selenized yeast 200 micrograms) | uvtnovuqpg(nijmuftgdj) = nqroweyrgj efguspceyh (gjshqgyjiy ) View more | Negative | 20 Jun 2010 | ||
Placebo | uvtnovuqpg(nijmuftgdj) = pnkvbkpxbd efguspceyh (gjshqgyjiy ) View more | ||||||
Phase 2 | Head and Neck Neoplasms selenium deficiency | 40 | Selenium supplementation | arbyjqrgfs(arhxbeoghl) = iohxffmpbb rvhbkzznkf (lkusqajugp ) View more | Negative | 01 Nov 2009 | |
arbyjqrgfs(arhxbeoghl) = indmlwucxd rvhbkzznkf (lkusqajugp ) View more | |||||||
Phase 2 | 39 | (Group A) | fsgsmrfeot(mrquwojhlk) = ebrpecjyst jugauanpwv (iqtynlwelp ) View more | Negative | 20 May 2009 | ||
(Group B) | fsgsmrfeot(mrquwojhlk) = nuwwtxyelt jugauanpwv (iqtynlwelp ) View more | ||||||
Phase 2 | 140 | Placebo | dlhbczlsnq(zrlamsdrib) = jxhbuvnkvo luaatwsclc (hguremmnhx ) | Negative | 20 May 2008 | ||
dlhbczlsnq(zrlamsdrib) = byytkhlesw luaatwsclc (hguremmnhx ) |





